Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GameStop Corp. (GME) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance

GameStop Corp.Trade
Kymera Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

GameStop Corp. vs Kymera Therapeutics Inc. Common Stock — how do they compare? GameStop Corp. trades at $26.47 (market cap $13.73B), while Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B). The key difference: GameStop Corp. is the larger of the two by market cap, and GameStop Corp. is trading nearer its 52-week high, Kymera Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GameStop Corp. for 62 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.

GMEKYMR
Market Cap
$13.73B$8.87B
Volume
12,710,661779,107
Sector
Consumer CyclicalHealth
52-Week High
$27.23$127.31
52-Week Low
$17.87$55.80
Typical Hold Time
62 Days0 Days
Enterprise Value
$13.01B$8.26B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GameStop Corp.

GME trades at $27.22, down slightly by 0.04% on the day. The stock shows strong technical momentum with bullish moving averages and positive price action near resistance at $28. Fundamentally, the company reported net income of $131.3 million in 2025 with improving profit margins of 25.16%, though revenue declined to $3.82 billion. Recent insider buying by CEO Ryan Cohen and directors has driven positive sentiment, with multiple purchases totaling over $26 million in September 2026.

GME presents a mixed outlook with strong insider confidence but challenging fundamentals. The investment opportunity lies in continued operational turnaround and potential strategic moves, while risks include revenue declines, competitive pressures in retail gaming, and the stock's meme stock volatility. Analyst consensus remains cautious with only 16.7% buy ratings versus 27.8% sells.

Kymera Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GME
29% Buy71% Sell
Avg holding period · 62 Days
KYMR
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About GameStop Corp.

Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.

Read more on GME →

About Kymera Therapeutics Inc. Common Stock

Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.

Read more on KYMR →